|
Mayur C. Maniar M.D.
mmaniar@smgumc.com
Board certified neurologist
with a special interest in Botox injections, chronic pain, headaches, as well as
muscle, neuropathies and nerve disorders.
PROFESSIONAL and
TEACHING ACTIVITIES
[2000-present] Private Practice
of Neurology, Sunrise Medical Group, Fort Lauderdale, FL
[1991-1999] Associates in Neurology, P.A., FL, Private
Practice
[1989-1991] Dunmore, P.A., Private Practice
[1988-1989] Hollywood, FL, Private Practice
[1987-1988] Staff, Henry Ford Hospital, Detroit, MI
MEDICAL
DEGREE
[1974-1978] University of Bombay, King Edward VII Memorial
Medical School, Bombay, India
CERTIFICATIONS, QUALIFICATIONS AND APPOINTMENTS
[1981-1983] Resident Education committee, University of Bombay
[1989] Diplomat, American Board
of Psychiatry and Neurology
[1983] Internal Medicine,
University of Bombay, Bombay, India
GRADUATE
TRAINING
Internship: Flexible
[1979-1980] (Flexible Internship,
University of Bombay, Bombay, India)
Externship:
Internal Medicine
[1983] (Externship in Internal Medicine, Wayne State University,
Detroit,
Michigan)
Residency:
Internal Medicine
[1980-1983] (Residency in
Internal Medicine University of Bombay, Bombay, India)
Residency:
Neurology
[1983-1986] (Henry Ford
Hospital, Detroit, Michigan.)
Fellowship:
Neuromuscular Disorder
[1986-1987] Fellowship in, (Henry Ford Hospital
Detroit, Michigan)
AFFILIATED
ASSOCIATIONS
American Academy of Neurology
American Association of Electrodiagnostic Medicine
RESEARCH,
PRESENTATIONS, PUBLISHED BOOKS AND PAPERS
[1987] “Evaluation of Weakness” for the Physician’s Assistant Program,
Henry Ford Hospital, Detroit, Michigan
[1984] “Entrapment Neuropathies of Lower extremities”,
Resident talk, Department of Neurology, Henry Ford Hospital
[1985] “Entrapment
Neuropathies of upper extremities”, Resident talk, Department of Neurology,
Detroit, Michigan
[1983] “Transient Global
Amnesia”, Resident talk, Department of Neurology, Henry Ford Hospital, Detroit,
Michigan
[1986-1987] Maniar, M.C., Glasberg, MR., Deegan, M.J:
Disappearance and Later Reappearance of serum IgC Kappa, subsequent to
prednisone therapy in server sensorimotor polyneuropathy. Presented at the
Michigan Neurological Association, Detroit, Michigan, 1986. Also submitted an
abstract for the meeting of American Academy of Neurology
[1982] Maniar, M.C., Patel, K: A study of risk factor
in cases of myocardial infarction with special reference to tobacco consumption:
Thesis, Bombay
[1987] Glasberg, M.R.,
Maniar, M.C., Angus, E.J., Ahmad, B.K.: Myopathic Muscle Biopsies in progressive
muscular atrophy. Submitted as an abstract for the meeting of the American
Academy of Neurology
[1999] BRAVO study
investigating the use of Lotrafiban for stroke and TIA prevention
[1998-1999] GAIN AMERICA trials investigating the use of GV150526
neuroprotective agent post-C VA
[1997] Post-Marketing
Studies: Trials investigating the use of Lamictal for treatment of partial
seizures
“Trials investigating the use
of Topomax for treatment of partial seizure”
“A Double-Blind Randomized
MultiCenter, Parallel Group Study to Establish Dose-Response, Safety And
Efficacy Zonegran ® (Zonisamide) as Monotherapy in patients with Newly Diagnosed
Epilepsy”
“A 6 week, Open Label,
Dose-comparison Study to Evaluate the Safety and Efficacy of Rosuvastatin Versus
Altorvastatin, Pravastatin, and Simvastatin in Subjects with
Hypercholesterolemia”
“An Open-label, Randomized,
Multi-center, Phase IlIb, Parallel Group Switching Study to Compare the Efficacy
and Safety of Lipid Lowering Agents Atorvatatin and Simvastatin with
Rosuvastatin I High Risk Subjects with Type lIa and lIb Hypercholesterolemia”
“A randomized, double-blind,
placebo-controlled, parallel-group study to evaluate the efficacy and
tolerability of oral sumatriptan 25mg, 50mg, and 100mg tablets for a single
moderate or severe headache in adults diagnosed with Migrainous disorder (HIS
1.7)”
“A Multicenter, double-blind,
randomized study to evaluate the safety and efficacy of lamotrigine 200mg/day,
300mg/day and 400mg/day compared with placebo in subjects with painful diabetic
neuropathy”
“An Open-Label Study to
Evaluate the Safety of Lamotrigine in Subjects with Painful Diabetic Neuropathy”
“A Multicenter, Double-blind,
Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy
and Safety of XXXXXX (200 mg/day, 400 mg/day, 600 mg/day) as Adjunctive Therapy
in Subjects with Partial Seizures with or without Secondary Generalization”
“An Open-label Extension Trial to Determine
Tolerability and Efficacy of Long-Term Oral XXXXX as Adjunctive Therapy in
Patients with Partial Seizures”
“Safety Evaluation of D-TRANS® fentanyl with
naltrexone HCI in Opiod Tolerant Patients”
“A Phase Ill, Randomized, Double-Blind,
Placebo-Controlled, Outpatient, safety and Efficacy Study of XXXXXX in Adult
Subjects with Chronic Insomnia”
“A Phase Ill, Randomized, Double-Blind,
Placebo-Controlled, Outpatient, safety and Efficacy Study of 00000 in Elderly
Subjects with Chronic Insomnia”
“A Phase II Double-Blind, Randomized, Dose-Ranging,
Placebo-Controlled, Multicenter, Safety and Efficacy Evaluation of Three Doses
of XXXXXX in Patients with Mild to Moderate Dementia of the Alzheimer’s Type”
“A Fourteen-Week Placebo-Controlled Dose-Response
Efficacy and Safety Study of XXXXXX in Early Parkinson’s Disease Patients”
“Study for Proof of Concept in Early Parkinson’s
Disease of a Triple Reuptake Inhibitor, XX XXXX / SCEPTRE”
“A Randomized Double-Blind, Placebo-Controlled,
Parallel-Group, Single-Attack Study to Evaluate the Onset of Efficacy of a New
Formulation of Sumatriptan Tablets 50mg and 100mg in the Acute Treatment of
Migraine”
“A dose-ranging,
placebo-controlled study of XXXX-XXXX-XX at the dose of 0.5 mg, 2 mg and 8 mg
for 12 weeks in patients with mild to-moderate Alzheimer’s Disease”
“A Randomized, Double-Blind,
Placebo Controlled Trial to Evaluate the Safety and Efficacy of XX-XXX 25 mg in
Slowing the Progression of Alzheimer’s Disease”
“A ONE YEAR, MULTICENTER,
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED EVALUATION OF THE EFFICACY AND
SAFETY OF DONEPEZIL HYDROCHLORIDE (XXXXX) IN SUBJECTS WITH MILD COGNITIVE
IMPAIRMENT”
“A two year Phase IlIb
randomized, multicenter, double-blind, placebo controlled, parallel group,
flexible dose study, to assess the effectiveness of controlled release
ropinirole add-on therapy to L-dopa at increasing the time to onset of
dyskinesia in Parkinson’s disease subjects”
“A 5-week, Randomized, Double-blind,
Placebo-controlled Multi-center Study of fS, S}-Reboxetine in Patients with
Postherpetic Neuralgia (PHN), who are Gabapentin Treatment Failures”
“A MultiCenter, open-label
trial to assess subject preference of PARCOPA, Carbidopai Levodopa Orally
Disintegrating Tablets, compared to conventional Carbidopa/Levodopa Tablets in
subjects with stable Parkinson’s Disease”
“A 4-Week Randomized,
Multicenter, Double-blind, Placebo-and Active-controlled, Parallel-group,
Forced-titration Phase lB Study Comparing Efficacy and Safety of Ascending Doses
of xxxxx”
“Prolonged Release Up To 233 mg BID and Oxycodone
Prolonged release up to 20 mg BID to Placebo in Subjects With Moderate to Severe
Chronic Pain Due to Osteoarthritis of the Knee”
“A Multi-Center, Randomized, Double-Blind, Placebo
Controlled Study Assessing the Safety and Efficacy of XX XXXXX in Patients with
Postherpetic Neuralgia”
“A Randomized,
Parallel-Design, Multi-center Study to Evaluate the Efficacy of AVINZA ® for the
Treatment of Chronic Low Back Pain”
“RANDOMIZED, DOUBLE-BLIND,
PLACEBO-CONTROLLED, PARALLEL GROUP PHASE 2 STUDY TO EVALUATE THE SAFETY AND
EFFICACY OF XXXXX IN SUBJECTS WITH MILD TO MODERATE ALZHEIMER’S DISEASE”
“A MULIT-CENTER, RANDOMIZED, DOUBLE-BLIND,
PLACEBO-CONTROLLED, PARALLEL-GROUP TRIAL TO ASSESS THE EFFICACY AND SAFETY OF
XXX XXX (200, 400, AND 600MG/DAY) IN SUBJECTS WITH PAINFUL DISTAL DIABETIC
NEUROPATHY”
“A randomized, double-blind,
parallel group. placebo-controlled, single-attack evaluation of the efficacy and
tolerability of Trexima (sumatriptan 85mg/ naproxen sodium SOOmgO tablets vs
placebo when administered during the mild pain phase of a migraine.”
“A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
TO ASSESS THE SUBJECTIVE RESPONSE TO TREATMENT WITH RAMELTEON IN ADULT SUBJECTS
WITH CHRONIC INSOMNIA BY UTILIZING AN INTERACTIVE VOICE RESPONSE SYSTEM (IVRS)
FOR COLLECTING DIARY DATA”
“Phase 3 Multicenter,
Randomized, Double Blind, Placebo Controlled Study of the Effect of Daily
Treatment with XXX XXX on Measures of Cognitive and Global Function in Subjects
with Mild to Moderate Dementia of the Alzheimer’s Type”
“A prospective,
multi-center, randomized, open-label study with blinded raters to evaluate the
effects of immediate versus delayed switch to Stalevo® on motor function and
quality of life in patients with Parkinson’s disease with end-of-dose wearing
off”
“A randomized, multi-center,
double-blind, placebo-controlled, 18-month study of the efficacy of Xaliproden
in patients with mild-to moderate dementia of the Alzheimer’s type”
“A MULIT-CENTER, RANDOMIZED, DOUBLE-BLIND,PLACEBO-CONTROLLED,
FIVE-ARM PARALLEL-GROUP TRIAL TO INVESTIGATE THE EFFICACY AND SAFETY OF FOUR
DIFFERENT TRANSDERMAL DOSES OF ROTIGOTINE IN SUBJECTS WITH IDIOPATHIC RESTLESS
LEGS SYNDOROME”
“AN OPEN-LABEL EXTENSION
TRIAL TO INVESTIGATE THE SAFETY AND TOLERABILITY OF LONG-TERM TREAMENT WITH
TRANSDERMAL ROTIGOTINE IN SUBJECTS WITH IDIPATHIC RESTLESS LEGS SYNDROME”
“A Pilot, Randomized,
Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Nortriptyline
HCI and Tramadol HCI in the Treatment of Chronic Lumbosacral Radiculopathy”
“A Randomized, Double-Blind,
Placebo-Controlled Study of the safety and Efficacy of Gabapentin extended
release (G-ER) Tablets in the Treatment of Patients with Postherpetic Neuralgia”
“An Open-label Exploratory
Study with Memantine of Selected Measures of Volumetric MRI and Cognition in
Patients with Moderate Dementia of the Alzheimer’s Type”
“SAFETY, TOLERABILITY, AND
EFFICACY STUDY OF ORAL KETASYNTM (AC-i 202) ADMINISTERED FOR NINETY
DAYS IN SUBJECTS WITH PROBABLE ALZHEIMER’S DISEASE OF MILD TO MODERATE
SERVERTIY”
“A PHASE 2, DOUBLE-BLIND,
RANDOMIZED, LACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER PROOF-OF-CONCEPT
STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ROZEREMTM TAKEN IN
COMBINATION WITH GABAPENTIN FOR THE TREATMENT OF SUBJECTS WITH CHRONIC INSOMNIA”
“A randomized, double-blind,
multi-center, placebo-controlled, cross-over study to determine the consistency
of response for TreximaTM (sumatriptan 85mg/naproxen sodium 500mg) administered
during the mild pain phase for the acute treatment of multiple migraine attacks”
“A Randomized, Double-Blind,
Placebo Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and
Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the
Treatment of Opioid-Induced Bowel Dysfunction in Adults taking Opioid Therapy
for Persistent Non-Cancer Pain”
“A Randomized, Double-Blind,
Placebo Controlled, Multicenter Phase 3 Study to Evaluate the Long-Term Safety
of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-lnduced
Bowel Dysfunction in Adults taking Opiod Therapy for Persistent Non-Cancer Pain”
“A Multicenter Study
Evaluating the Efficacy and Safety of Botox® (Botulinum Toxin Type A) Purified
Neurotoxin Complex as Headache Prohylaxis in Migraine Patients with 15 or More
Headache Days per 4-Week Period in a 24-Week, Double Blind, Randomized,
Placebo-Controlled, Parallel-Group Phase Followed by a 32-Week Open-Label
Extension”
“A Double-Blind, Randomized,
Placebo-Controlled Study of the Efficacy, Safety and Tolerability of B Week
Treatment of Rozerem 8 mg (QHS) in Sleep Disturbed, Community Dwelling, Mild to
Moderately Sever Alzheimer’s Disease Subjects
“A randomized, double-blind,
placebo controlled, parallel-group clinical trial to examine the efficacy and
safety of early pramipexole treatment versus delayed pramipexole treatment in
patients with new onset Parkinson’s disease”
“[5, 51-REBOXETINE
DOSE-RANGE FINDING TRIAL: A 16-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO AND
PREGABALIN CONTROLED, MULTI-
CENTER TRIAL OF [S,SJ-REBOXETINE IN PATINETS WITH POSTHERPETIC
NEURALGIA (PHN.)”
“A Randomized, Double-Blind,
Placebo-Controlled, Multi-Center, Phase 2 Study Designed to Assess the Efficacy
and Safety of XXXXXX in Subjects with Painful Diabetic Neuropathy”
“A Randomized, Double-Blind,
Active-Control, Parallel Group, 90-Day Safety Study of XXX)(XX Immediate Release
or Oxycodone Immediate Release in Subjects With Chronic Pain From Low Back Pain
or Osteoarthritis of the Hip or Knee”
“A Multicenter Trial
Evaluating the Efficacy of Cesamet1”~ for the Symptomatic Treatment
of Pain in Patients with Multiple Sclerosis”
“A Multicenter Trial
Evaluating the Efficacy of CesamerM for the Symptomatic Treatment of Pain in
Patients with Diabetic Peripheral Neuropathy”
“A Prospective, Multi-Center
Clinical Evaluation of the Eon~ 16 Channel Implantable Pulse Generator (IPG) in
combination with a lead tripole array for the management of chronic back pain
with or without leg pain”
“A Multi-Center, Randomized,
Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy. Safety
and Tolerability of XXXX in Levodopa Treated Parkinson’s Disease Patients with
Motor Fluctuations”
“AN OPEN-LABEL EXTENSION
TRIAL ASSESSING THE SAFETY AND TOLERABILITY OF [S, S]-REBOXETINE IN PATIENTS
WITH POSTHERPETIC NEURALGIA (PHN)”
| 